These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3498133)

  • 41. Resistance of golden hamster to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship with low levels of regional monoamine oxidase B.
    Mitra N; Mohanakumar KP; Ganguly DK
    J Neurochem; 1994 May; 62(5):1906-12. PubMed ID: 8158138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
    Herraiz T; Arán VJ; Guillén H
    Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoamine oxidase B, smoking, and Parkinson's disease.
    Yong VW; Perry TL
    J Neurol Sci; 1986 Feb; 72(2-3):265-72. PubMed ID: 3486945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selegiline and the prophylaxis of Parkinson's disease.
    Sandler M; Willoughby J; Glover V; Gibb C
    J Neural Transm Suppl; 1987; 25():35-43. PubMed ID: 3123604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW; Irwin I; Langston EB; Forno LS
    Science; 1984 Sep; 225(4669):1480-2. PubMed ID: 6332378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae.
    Trevor AJ; Castagnoli N; Caldera P; Ramsay RR; Singer TP
    Life Sci; 1987 Feb; 40(8):713-9. PubMed ID: 3492651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The ex vivo effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on rat intra- and extraneuronal monoamine oxidase activity.
    Arai Y; Toyoshima Y; Kinemuchi H; Tadano T; Kisara K
    Neurosci Lett; 1986 Oct; 70(2):266-71. PubMed ID: 3490638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a rat pheochromocytoma cell line, PC12h.
    Naoi M; Takahashi T; Nagatsu T
    Life Sci; 1987 Dec; 41(24):2655-61. PubMed ID: 3121966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MPTP fails to induce lipid peroxidation in vivo.
    Corongiu FP; Dessi' MA; Banni S; Bernardi F; Piccardi MP; Del Zompo M; Corsini GU
    Biochem Pharmacol; 1987 Jul; 36(14):2251-3. PubMed ID: 3496886
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
    Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time-dependent inhibition of rat brain monoamine oxidase by an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 4-(4-chlorophenyl)-1,2,3,6-tetrahydropyridine.
    Arai Y; Hamamichi N; Kinemuchi H
    Neurosci Lett; 1986 Oct; 70(2):255-60. PubMed ID: 3490636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
    Sonsalla PK; Youngster SK; Kindt MV; Heikkila RE
    J Pharmacol Exp Ther; 1987 Sep; 242(3):850-7. PubMed ID: 2888874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary.
    Gibb C; Willoughby J; Glover V; Sandler M; Testa B; Jenner P; Marsden CD
    Neurosci Lett; 1987 May; 76(3):316-22. PubMed ID: 3495757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potent neurotoxic fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs as potential probes in models of Parkinson disease.
    Riachi NJ; Arora PK; Sayre LM; Harik SI
    J Neurochem; 1988 Apr; 50(4):1319-21. PubMed ID: 3258018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of rat brain monoamine oxidase by some analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion.
    Arai Y; Kinemuchi H; Hamamichi N; Satoh N; Tadano T; Kisara K
    Neurosci Lett; 1986 May; 66(1):43-8. PubMed ID: 3487053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
    Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP
    Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.